These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 27121353

  • 1. Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.
    Xi LF, Schiffman M, Koutsky LA, Hughes JP, Hulbert A, Shen Z, Galloway DA, Kiviat NB.
    Int J Cancer; 2016 Sep 01; 139(5):1098-105. PubMed ID: 27121353
    [Abstract] [Full Text] [Related]

  • 2. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB.
    Int J Cancer; 2017 Apr 15; 140(8):1747-1756. PubMed ID: 28052328
    [Abstract] [Full Text] [Related]

  • 3. Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.
    Xi LF, Schiffman M, Koutsky LA, Hughes JP, Winer RL, Mao C, Hulbert A, Lee SK, Shen Z, Kiviat NB.
    J Natl Cancer Inst; 2014 Oct 15; 106(10):. PubMed ID: 25217779
    [Abstract] [Full Text] [Related]

  • 4. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
    Li X, Ding L, Song L, Gao W, Wang L, Wang J.
    Int J Cancer; 2020 May 01; 146(9):2406-2412. PubMed ID: 31290154
    [Abstract] [Full Text] [Related]

  • 5. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
    Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB.
    Cancer Epidemiol Biomarkers Prev; 2019 Aug 01; 28(8):1388-1394. PubMed ID: 31101617
    [Abstract] [Full Text] [Related]

  • 6. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
    Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K, Kita T, Yamamoto K, Mikami M, Takizawa K, Japanese Gynecologic Oncology Group (JGOG).
    J Obstet Gynaecol Res; 2014 Feb 01; 40(2):561-9. PubMed ID: 24147758
    [Abstract] [Full Text] [Related]

  • 7. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
    Bogani G, Pinelli C, Chiappa V, Martinelli F, Lopez S, Ditto A, Raspagliesi F.
    J Gynecol Oncol; 2020 Sep 01; 31(5):e60. PubMed ID: 32808492
    [Abstract] [Full Text] [Related]

  • 8. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A, Dominoni M, Boschi AC, Cesari S, Fiandrino G, Gardella B.
    Gynecol Oncol; 2020 Dec 01; 159(3):630-635. PubMed ID: 33041069
    [Abstract] [Full Text] [Related]

  • 9. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.
    J Gynecol Oncol; 2017 Jul 01; 28(4):e30. PubMed ID: 28541628
    [Abstract] [Full Text] [Related]

  • 10. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
    Smelov V, Elfström KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlström L, Dillner J.
    Int J Cancer; 2015 Mar 01; 136(5):1171-80. PubMed ID: 25043476
    [Abstract] [Full Text] [Related]

  • 11. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3.
    Xi LF, Schiffman M, Koutsky LA, Hulbert A, Lee SK, Defilippis V, Shen Z, Kiviat NB.
    Int J Cancer; 2012 Nov 15; 131(10):2300-7. PubMed ID: 22396129
    [Abstract] [Full Text] [Related]

  • 12. Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse.
    Feng RM, Hu SY, Zhao FH, Zhang R, Zhang X, Wallach AI, Qiao YL.
    J Gynecol Oncol; 2017 Sep 15; 28(5):e47. PubMed ID: 28657217
    [Abstract] [Full Text] [Related]

  • 13. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
    Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, Harper DM, Levin MJ, Chatterjee A, Geeraerts B, Struyf F, Dubin G, Bozonnat MC, Rosillon D, Baril L, VIVIANE Study Group.
    Int J Cancer; 2016 May 15; 138(10):2428-38. PubMed ID: 26685704
    [Abstract] [Full Text] [Related]

  • 14. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia.
    Chang YJ, Chen HC, Lee BH, You SL, Lin CY, Pan MH, Chou YC, Hsieh CY, Chen YM, Cheng YJ, Chen CJ, CBCSP-HPV Study Group.
    Int J Cancer; 2011 Aug 15; 129(4):965-73. PubMed ID: 20949622
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
    Kelly HA, Sawadogo B, Chikandiwa A, Segondy M, Gilham C, Lompo O, Omar T, Didelot MN, Nagot N, Meda N, Weiss HA, Delany-Moretlwe S, Mayaud P, HARP Study Group.
    AIDS; 2017 Jan 14; 31(2):273-285. PubMed ID: 27755107
    [Abstract] [Full Text] [Related]

  • 16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 14; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z.
    Medicine (Baltimore); 2016 Jan 14; 95(3):e2555. PubMed ID: 26817906
    [Abstract] [Full Text] [Related]

  • 18. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T, Hasegawa T, Ochiai K, Takizawa K, Umezawa S, Kuramoto H, Ohmura M, Kubushiro K, Arai H, Sakamoto M, Motoyama T, Watanabe K, Aoki D.
    Reprod Sci; 2015 Dec 14; 22(12):1509-15. PubMed ID: 26092278
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A, de Oliveira CF, Lopes C, Cunha MJ, CLEOPATRE Portugal Study Groupa.
    Int J Gynecol Cancer; 2013 Mar 14; 23(3):500-6. PubMed ID: 23392401
    [Abstract] [Full Text] [Related]

  • 20. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.
    BJOG; 2006 Nov 14; 113(11):1303-7. PubMed ID: 16978225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.